- Subjects who are not surgically sterile or postmenopausal (amenorrheic > 12 months) must agree and commit to the use of a medically acceptable, highly–effective (i.e. double-barrier or IUD), non-hormonal form of birth control during the study and for 30 days after the last dose of test